DFX Intelligence

Venture Capital Intelligence

Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / CND Life Sciences, Inc.

CND Life Sciences, Inc.

GrowthScottsdale, AZBiotechnology

Facts

Year of incorporation: unknown
Revenue range (Form D): Decline to Disclosesec.gov
Rounds on record: 3
Disclosed raised: unknownsum of rounds with a disclosed amount only
Named investors: 1

Financing history

3 rounds

Aug 4, 2026
Growth Financing · amount undisclosed
S-Curve Partners (lead) via Daniel Livschutz
Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “CND Life Sciences Announces Growth Financing Led by S-Curve Partners to Accelerate Expansion of the Syn-One Test® Platform and the Company's Precision Neurology Mission”
Feb 28, 2025
Form D equity offering · $3.5M (form d sold) · 26 investors
Fact SEC EDGAR Form D data sets (quarterly) · “CND Life Sciences, Inc. filed Form D: $3,514,565 sold of $7,500,000, Biotechnology”
Mar 20, 2024
Form D equity offering · $2.0M (form d sold) · 22 investors
Fact SEC EDGAR Form D data sets (quarterly) · “CND Life Sciences, Inc. filed Form D: $2,007,000 sold of $6,000,000, Biotechnology”

Investors on record

1 edges

S-Curve Partners round, lead, Daniel Livschutz (confirmed) Fact prnewswire.com

People

3 officers, 4 directors

Peter J. Harris Executive Officer/Director sec.gov
Richard J. Morello Executive Officer/Director sec.gov
Todd J. Levine Executive Officer/Director sec.gov
Peter J. Harris Director Fact
Enrique J. Carrazana Director Fact
Jack J. Seaver Director Fact
Christopher J. Gibbons Director Fact

Timeline

Aug 4, 2026
CND Life Sciences announced Growth Financing, led by S-Curve Partners
Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
May 6, 2025
CND Life Sciences, Inc. filed Form D/A: $8,648,469 sold of $9,000,000, Biotechnology
Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Apr 15, 2025
CND Life Sciences, Inc. filed Form D/A: $3,664,565 sold of $9,000,000, Biotechnology
Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Mar 6, 2025
CND Life Sciences, Inc. filed Form D: $3,514,565 sold of $7,500,000, Biotechnology
Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Mar 27, 2024
CND Life Sciences, Inc. filed Form D: $2,007,000 sold of $6,000,000, Biotechnology
Form D filed Fact SEC EDGAR Form D data sets (quarterly)

Evidence

57 observations

Every observation on this company

Entity type: Corporation May 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Entity type: Corporation Apr 15, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Entity type: Corporation Mar 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Entity type: Corporation Mar 27, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Form D industry group: Biotechnology May 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Form D industry group: Biotechnology Apr 15, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Form D industry group: Biotechnology Mar 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Form D industry group: Biotechnology Mar 27, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Amendment: true May 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Amendment: true Apr 15, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Amendment: false Mar 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Amendment: false Mar 27, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Revenue range (Form D): Decline to Disclose May 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Revenue range (Form D): Decline to Disclose Apr 15, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Revenue range (Form D): Decline to Disclose Mar 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Revenue range (Form D): Decline to Disclose Mar 27, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Incorporated: overFiveYears May 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Incorporated: overFiveYears Apr 15, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Incorporated: overFiveYears Mar 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Incorporated: overFiveYears Mar 27, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Jurisdiction: DELAWARE May 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Jurisdiction: DELAWARE Apr 15, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Jurisdiction: DELAWARE Mar 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Jurisdiction: DELAWARE Mar 27, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Amount sold (Form D): $8.6M May 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Amount sold (Form D): $3.7M Apr 15, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Amount sold (Form D): $3.5M Mar 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Amount sold (Form D): $2.0M Mar 27, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Offering amount (Form D): $9.0M May 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Offering amount (Form D): $9.0M Apr 15, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Offering amount (Form D): $7.5M Mar 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Offering amount (Form D): $6.0M Mar 27, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Exemptions: 06b May 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Exemptions: 06b Apr 15, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Exemptions: 06b Mar 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Exemptions: 06b Mar 27, 2024 Fact SEC EDGAR Form D data sets (quarterly)
First sale: 2025-02-28 May 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
First sale: 2025-02-28 Apr 15, 2025 Fact SEC EDGAR Form D data sets (quarterly)
First sale: 2025-02-28 Mar 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
First sale: 2024-03-20 Mar 27, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Investors (Form D): 38 May 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Investors (Form D): 27 Apr 15, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Investors (Form D): 26 Mar 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Investors (Form D): 22 Mar 27, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Minimum investment (Form D): 25,000 May 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Minimum investment (Form D): 25,000 Apr 15, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Minimum investment (Form D): 25,000 Mar 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Minimum investment (Form D): 25,000 Mar 27, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Securities offered: equity May 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Securities offered: equity Apr 15, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Securities offered: equity Mar 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Securities offered: equity Mar 27, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Office address: 9165 E. DEL CAMINO DRIVE, SUITE 101, SCOTTSDALE, AZ, 85258-4381 May 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Office address: 9165 E. DEL CAMINO DRIVE, SUITE 101, SCOTTSDALE, AZ, 85258-4381 Apr 15, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Office address: 9165 E. DEL CAMINO DRIVE, SUITE 101, SCOTTSDALE, AZ, 85258-4381 Mar 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Office address: 9165 E. DEL CAMINO DRIVE, SUITE 101, SCOTTSDALE, AZ, 85258-4381 Mar 27, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Round announced: Growth Financing Aug 4, 2026 Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)